Program Director: Udai Kammula, MD
This training program is to prepare up to three surgical residents for a career as translational scientists in the field of biologic therapy of cancer. This training grant is funded through the National Cancer Institute of the National Institutes of Health (NIH). Trainees will be exposed to an immersive experience that will stress three core proficiencies necessary to be a successful translational scientist, including, basic laboratory research skills, fundamental principles of clinical investigation, and pragmatic experience in clinical trial management.
Eligibility Section
Candidates must have a MD or MD/PhD, be a categorical surgical resident or a surgical oncology fellow, have a strong interest in cancer research and a desire for an academic career in surgical oncology. Candidates need to possess integrity, perseverance, good communication skills, self-motivation, and strong recommendations. As stipulated by the granting agency, Candidate must be a US citizen or a US permanent resident.
To Apply Section
If you are interested, please email a one-page description of your research interests and long-term professional goals, current CV, and two letters of recommendation (one of which should be from your Program Director or Thesis Advisor indicating your ability to participate in this program for two years and another from your Department Chair) to Donielle Neal, Academic Program Administrator, meskdy@pitt.edu.
Training Faculty
|
Udai Kammula, MD |
Tumor Immunology, Adoptive Cellular Therapy |
| Stephen Badylak, MD |
Tissue engineering/ Regenerative medicine; Biologic scaffolds and extracellular matrix (ECM) biology; Clinical translation; Cell:biomaterial interactions; Epimorphic regeneration in mammals; Musculotendinous tissue reconstruction; CNS regenerative medicine; Use of naturally occurring biomaterials to promote stem cell survival and differentiation |
|
Tuillia Bruno, PhD |
Tumor Immunology, B cells, T cells, Tertiary Lymphoid Structures |
| Haroon Choudry, MD | Targeted therapies for mucinous tumors |
| Robert Ferris, MD | Pre-clinical and clinical development of novel immunotherapies for head and neck cancers |
| Andrea Gambotto, MD | Immunotherapy, Genetic engineering, vaccine development |
| David Geller, MD | HCC/mCRC signaling |
| Timothy Hand, PhD | Mucosal immunology; Lymphocyte immune responses in the intestine |
| Gary Kohanbash, PhD |
Brain Tumor Immunology |
| Adrian Lee, PhD | Breast Cancer |
| Yong Lee, PhD | Multimodal approach for peritoneal carcinomatosis |
| Jason Lohmueller, PhD | Synthetic biology, Protein engineering, Adoptive T cell therapy, Gene therapy |
|
Carissa Low, PhD |
Mobile technology for remote cancer patient monitoring & adaptive behavioral interactions |
| Walter Storkus, PhD | Cancer Immunology |
| Lin Zhang, PhD | Apoptosis and necrotic cell death; colorectal cancer therapies and prevention |